How can we bring public health in all policies? Strategies for healthy societies

New scenarios are emerging in the European and worldwide context: the ageing of society, the climate changes, the increasing of health inequalities and the financial crisis. In this context, the scientific community and the decision-makers agree on the role of health in all policies (HiAP) strategy in improving the population’s health. The HiAP takes into account factors not strictly related to health but with important health consequences. To bring public health in all policies a change is needed, but there are some obstacles to overcome: for instance, the lack of evidence regarding the governance tools and frameworks for HiAP, the difficulty of convincing stakeholders and producing a cultural change in the political positioning of decision-makers. Consequently, it is necessary: i) to implement stronger and responsible decision-support approaches, such as health impact assessment and health technology assessment; ii) to encourage and coordinate all relevant sectors in playing their part in reducing health gaps within the European Union; iii) to strengthen cooperation and make better use of existing networks and existing public health and related institutions. The final aim will be to monitor the impact of the health determinants in order to promote the effective implementation of HiAP approach

Effectiveness Cost of HIV rapid tests in Italy and Europe

In the United States, about a quarter of the estimated 1.1 million people living with human immunodeficiency virus (HIV) are not aware of their HIV status. HIV tests in communities with outreach settings can be an effective strategy to identify people with unidentified HIV infection. The spread of innovative rapid tests represents an additional opportunity in the field of HIV prevention. HIV rapid tests represent an excellent diagnostic tool to reach the rural or poor population where accessibility to test is limited or populations with high-risk infection. Cost-effectiveness point of view, this service always has the potential for early diagnosis by affecting lower hospital spending, preventing clinically aggravated cases with decreased CD4 and acquired immunodeficiency. The study analyses the characteristics of rapid tests by evaluating what can be used in Europe and Italy from case studies. The sensitivity, specificity and project needs are the main factors of choice in testing project

Cross sectional study investigating the differences in knowledge and behaviors about HPV between vaccinated and non-vaccinated girls

IntroductionThe aim of the presents study was to compare the level of knowledge about Human Papilloma Virus (HPV) in vaccinated and non-vaccinated girls and to highlight the reasons why non-vaccinated girls refuse vaccination.MethodsA cross-sectional study was conducted from October 2012 to June2013 inTurin (Piemonte Region, Italy). Questionnaires were administered to girls attending secondary and high schools randomly selected.ResultsA total of 576 were compiled. The principle sources of information were parents and health workers. The main reported reasons for non-adherence to vaccination were the disagreement of the parents among the 11-12 years group (45.3%) and the lack of evidence on efficacy among the 18 years group (26.8%). By comparing the level of knowledge there was a statistically significant difference between groups: vaccinated girls reported higher score than the unvaccinated group in several questions (p≤0.05).DiscussionOur findings show a lack of information about HPV infection. Parents, school and health care workers have a central role in girlâs education and choices about HPV vaccination.The communication campaign for the prevention of cervical cancer must therefore be characterised by messages able to clarify and consolidate messages that may have been partially received or misunderstood